CytoLynx Therapeutics

company

About

CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.

Details

Last Funding Type
Funding Round
Last Funding Money Raised
$45M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2021
Operating Status
Active

CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$45M
CytoLynx Therapeutics has raised a total of $45M in funding over 2 rounds. Their latest funding was raised on Sep 13, 2021 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 13, 2021 Funding Round $45M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CytoLynx Therapeutics is funded by 1 investors. Ruihua Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Ruihua Venture Capital Funding Round